|
Originally published In Press as doi:10.1074/jbc.M203462200 on July 29, 2002
J. Biol. Chem., Vol. 277, Issue 40, 37349-37358, October 4, 2002
Urea-dependent Signal Transduction by the
Virulence Regulator UreR*
Inessa
Gendlina,
Delia M.
Gutman,
Venetta
Thomas , and
Carleen M.
Collins§
From the Department of Microbiology and Immunology, University of
Miami School of Medicine, Miami, Florida 33101
Received for publication, April 10, 2002, and in revised form, June 27, 2002
 |
ABSTRACT |
Identification of the environmental triggers
involved in the expression of virulence genes is a fundamental
objective in studies of bacterial pathogens. For uropathogens, urea,
found in the urinary tract at concentrations of up to 500 mM, functions as an environmental signal. Urea freely
diffuses into the bacterium Providencia stuartii and
activates UreR, a member of the AraC family of transcriptional activators. Active UreR promotes transcription of virulence-associated urease genes and alerts the organisms of its immediate milieu. Thus,
the UreR·urea complex has a dual role, acting as both a transcriptional activator as well as an environmental sensor. Here, we
describe the molecular events associated with activation of gene
expression by urea-bound UreR. The Kd of the urea·UreR binding reaction was measured as 0.2 mM by
fluorescence quenching assays, and the shape of the binding curve
indicated a single specific urea-binding site on UreR. Histidine
residues are critical for urea binding in urease, and therefore to
identify the urea-binding site in UreR, five mutant UreR forms were
generated with histidine to alanine substitutions. Two of the mutants
(UreRc) exhibited a constitutive phenotype by both
activating transcription and binding to DNA with an increased affinity
in the absence of urea. The UreRc bound urea with an
affinity similar to that of wild-type UreR. We concluded, therefore,
that the mutations resulting in constitutive activity were not involved
in the UreR·urea interaction. UreR was activated, then, either by
binding urea or by histidine to alanine substitutions at one of two
positions. Circular dichroism indicated little change in the structure
of UreR when activated, and size-exclusion chromatography demonstrated
that both rUreR and rUreRc were dimers in both the
presence and absence of urea. Thus, the structural changes associated
with activation are subtle.
 |
INTRODUCTION |
Bacterial pathogens transcribe genes necessary to establish an
infection, proliferate, and overcome host defense mechanisms in
response to environmental signals. The most well studied environmental sensing mechanisms involve signal transduction pathways that originate at the bacterial cell envelope and activate cytoplasmic response regulators (1). Environmental signals alerting the organisms of the
appropriate host niche include temperature, osmolarity, pH, and metal
ions (2). For the majority of virulence-associated genes, however, the
sensing and signaling mechanisms and exact in vivo stimuli
are not known.
Upon colonization of the urinary tract, uropathogenic bacteria express
a specific armament of proteins. These proteins include attachment
factors or pili, hemolysin, the iron scavenger aerobactin, and the
enzyme urease (3-5). In the urinary tract urease is an important
contributor to the virulence of the organism (6-8). Urease catalyzes
the hydrolysis of urea to ammonia and carbon dioxide, and the resulting
ammonium elevates urine pH. This results in a more favorable
environment for bacterial growth and leads to an increase in bacterial
proliferation. In addition, the elevated urine pH facilitates formation
of urinary stones, comprised of magnesium ammonium phosphate salts
(struvite) (7, 8). The struvite precipitates can be found in the renal
pelvis, the bladder, and encrusted on urinary catheters. Stone
formation can cause urinary obstruction and interfere with voiding,
thereby making it more difficult to clear the infecting organism from
the urinary tract (9, 10). Stones can also harbor the infecting
bacteria in a protected site (11). In addition to stone formation, the basic urine damages the uroepithelium, inhibits the action of complement, and reduces the efficiency of certain antibiotics.
Providencia stuartii is one of the most frequently isolated
ureolytic uropathogens (12, 13). In P. stuartii, the urease genes are found on large plasmids ranging from 82 to 230 kb in size and
are termed the plasmid-encoded urease gene cluster (14-16). Similar
plasmids are found in ureolytic Escherichia coli and
Salmonella species. Seven tandem genes in this
plasmid-encoded urease cluster code for urease subunits
(ureABC) and accessory polypeptides (ureDEFG), which are needed to form the nickel metallocenter found in the active
enzyme (17, 18). An eighth gene, termed ureR, is found 414 bp upstream and divergently transcribed from the ureDABCEFG cluster (19). The ureR gene product, UreR (34.1 kDa), is a
member of the AraC family of transcriptional activators and is required for transcription at ureDp, ureGp, and
ureRp (19, 20).
In addition to UreR, transcription from each of these promoters is
dependent upon the presence of urea. Previous studies indicate UreR
binds upstream of ureRp and ureDp, and the
affinity of UreR for the DNA-binding sites increases significantly in
the presence of urea (21). It is evident that UreR can take on one of
two conformations, binding DNA with either high or low affinity.
However, the molecular mechanisms responsible for UreR activation have not been determined.
In the urinary tract, urea is found at concentrations of up to 500 mM, and this concentration is at least 50-fold higher than urea concentrations found at other sites in the body. Urea is able to
freely diffuse into P. stuartii and other enteric bacteria. Thus, in this system, urea is acting not only as an effector molecule but also as the environmental signal, alerting P. stuartii that it has entered the appropriate site to initiate
infection. In fact, the urea·UreR interaction is one of the first
signals to the uropathogen that it has entered a urinary tract. Studies
reported here are aimed to better understand this signaling mechanism
by characterizing the transcriptionally active UreR.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Chemicals were obtained from Sigma-Aldrich and
Invitrogen, unless otherwise specified. Restriction enzymes and enzyme
buffers were obtained from New England BioLabs, and custom synthesized oligonucleotides were purchased from the Great American Gene Company and Ransom Hill Bioscience, Inc. RNA polymerase was obtained from Amersham Biosciences, and [32P]dCTP (3000 mCi/mmol and 10 mCi/ml) was purchased from ICN Pharmaceuticals.
Bacterial Strains and Growth
Conditions--
Bacterial strains used are listed in Table
I. Bacteria were grown in Luria-Bertani
(LB) broth with aeration at 37 °C or on LB broth solidified
with 1.5% agar. Media were supplemented with carbenicillin at 75 mg/ml, ampicillin at 100 mg/ml, tetracycline at 20 mg/ml, or kanamycin
at 25 mg/ml when indicated.
Generation of Point Mutations in ureR--
Mutant
ureR were generated using overlap extension PCR with
oligonucleotides containing the desired nucleotide substitutions (22).
Specifically, two partial ureR products were amplified from
the urease encoding pSEF70 (20) with 20-bp oligonucleotides containing
the desired mutation. The amplified products were purified and used as
template for a second PCR amplification with external flanking primers
to yield a full-length, mutated ureR-encoding fragment. The
complete double-stranded DNA sequence of each resultant UreR-encoding
fragment was determined to ensure that only the single desired mutation
was present.
Two plasmid constructs were generated for each ureR mutant.
For in vivo studies, ureR and mutant
ureR DNA fragments were amplified such that they contained
terminal HindIII and BamHI endonuclease recognition sites. The native ureRp was not present on these
fragments. The ureR-encoding fragments were inserted in the
low copy number pRK415 downstream of the lactose operon promoter
lacZp, which controlled transcription of ureR and
mutants. For in vitro studies, the ureR-encoding
fragments were generated to contain terminal NdeI and
BamHI restriction endonuclease recognition sites, to allow
insertion into, and expression from, pET15b (Novagen). The complete
list of recombinant plasmids used is presented in Table I.
-Galactosidase Assay--
To determine the transcriptional
activity of the mutant UreR, UreR-encoding pRK415 derivatives were
transformed into Escherichia coli containing a single
chromosomal copy of ureRp-lacZ (SF07-1) or
containing a single chromosomal copy of
ureDp-lacZ (SF15). Cultures were grown with
aeration at 37 °C overnight in LB supplemented with tetracycline.
Stationary phase cultures were diluted in 1× Christensen broth (0.1%
peptone, 0.5% NaCl, 0.1% glucose, 0.2% KH2PO4, 10 mM MgCl2,
and 10 nM NiCl2) supplemented with 1% urea when indicated. Cells were grown to mid-logarithmic phase and assayed
for -galactosidase activity as previously described (23). Each
sample was assayed in triplicate, a minimum of three independent times.
Western Blot Analysis--
Western blots were preformed by
standard protocols. Cell cultures used for -galactosidase activity
determination were centrifuged, and cell pellets were resuspended at
equal cell densities in 20 µl of water. An equal volume of 2×
denaturing protein buffer (100 mM Tris-HCl, pH 6.8, 4%
SDS, 0.2% bromphenol blue, 20% glycerol, 10% 2-mercaptoethanol) was
added, and samples were boiled for 5 min, loaded onto 12% SDS-PAGE,
and resolved at 120 V overnight. Proteins were transferred onto a
nitrocellulose membrane using Trans-Blot electrophoretic transfer cell
(Bio-Rad). Western blotting was performed according to the ECL Western
blotting analysis system protocol (Amersham Biosciences) using a 1:3000
dilution of polyclonal rabbit anti-UreR antibody and 1:5000 dilution of
peroxidase-labeled anti-rabbit antibody.
Purification of rUreR--
The Novagen E. coli
expression system was used to generate recombinant UreR
(rUreR).1 UreR-encoding
sequences were inserted in-frame into pET15b, an expression plasmid
that codes for an N-terminal leader peptide containing six histidine
residues and a thrombin cleavage site. Expression from the plasmid and
initial purification were as described by the manufacturer. E. coli BL21(DE3) containing wild-type and mutant ureR
were grown to mid-exponential phase in LB broth supplemented with 1 mM
isopropyl-1-thio- -D-galactopyranoside. Cells were
pelleted by centrifugation and lysed by passage through a French
pressure cell. rUreR was separated from the cell lysate by affinity
chromatography over the His-Bind affinity resin (Novagen). rUreR was
eluted from the column with an imidazole gradient, and rUreR containing
fractions were collected and dialyzed into a buffer of 50 mM Bis-Tris, pH 6.5, 100 mM EDTA, 300 mM NaCl, and 15% glycerol.
A MBP-UreR fusion proteins was also purified. Wild-type UreR-encoding
sequence was inserted in-frame into pMAL-c2E (New England BioLabs)
expression plasmid, thereby generating a translational MBP-UreR fusion.
Protein expression and purification were performed according to the
manufacturer's protocol. E. coli DH5 (pIG1.11) were
grown in LB supplemented with glucose and 1 mM
isopropyl-1-thio- -D-galactopyranoside, and cells were
pelleted and lysed as above. MBP-UreR was purified by affinity
chromatography over Amylose resin (New England BioLabs) and eluted with
buffer containing 10 mM maltose, 20 mM
Tris-HCl, 200 mM NaCl, and 1 mM EDTA.
Fraction purity was assessed by SDS-PAGE and Coomassie Blue
staining. Total protein concentration was determined using the BCA
Protein Assay kit (Pierce) or Bradford protein assay. rUreR refers to
the wild-type protein with an N-terminal histidine tag, and MBP-UreR
refers to the N-terminal maltose binding protein fusion. Proteins were
kept at 4 °C for immediate use and kept at 20 °C for long term storage.
Radiolabeling of DNA Fragments--
Plasmid DNA (30-50 µg)
was linearized with either SpeI (pIG0.2, for
ureDp fragment) or XhoI (pVJT9, containing a
147-bp intergenic region) and radiolabeled by incubating with the
Klenow fragment of DNA polymerase I (1.5 µl of 5 units/ml)(New
England BioLabs), 2 mM cold NTPs (G, A, T), and 5 µl of
[32P]dCTP (10 mCi/ml) in a final volume of 50 µl at
37 °C for 30 min. Enzymes were inactivated at 75-90 °C for 10 min. Fragments were released by digestion with either EcoRI
(pIG0.1 and pIG0.2) or HindIII (pVJT9) and were separated on
4% native polyacrylamide gel (38:2 acrylamide:bisacrylamide) in TBE
buffer (100 mM Tris, pH 8.0, 100 mM boric acid,
5 mM EDTA) for 3-4 h at 120 V. Labeled fragments were
localized by brief exposure to radiographic film, excised from the gel,
and eluted overnight at 37 °C in two volumes of elution buffer (0.5 M ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA, pH 8.0, 0.1% SDS). Eluted DNA was precipitated in
two volumes of 95% ethanol and resuspended in 50 ml of 0.1× TE buffer (1 mM Tris-HCl, 0.1 mM EDTA, pH 8.0).
Typically, 5-10 ng of DNA was recovered, ranging from 1,000 to 50,000 cpm.
Electrophoretic Mobility Shift Assay--
Radiolabeled DNA
(2000-5000 cpm or 0.5-1 ng) was incubated with varying concentration
of rUreR in 25 µl of 10 mM Tris HCl (pH 8.0), 100 mM NaCl, 90 mM KCl, 0.125 mM
dithiothreitol, 2 mM EDTA, 12.5 mg/ml bovine serum albumin,
12.5% glycerol, and 150-200 ng of poly(dI-dC) (Fluka BioChemika) for
30 min at room temperature. When indicated, 50 mM urea was
present. Reactions were then loaded onto 5% native polyacrylamide gel
and resolved in Tris-glycine buffer (50 mM Tris, 100 mM glycine, and 2 mM EDTA) for 3 h at 150 V. Gel was vacuum-dried and exposed to radiographic film overnight at
70 °C.
Dissociation Rate Constant Determination--
rUreR (28 nM final concentration) was incubated with radiolabeled
88-bp ureDp fragment (1.6 nM, from pIG0.2) in
the presence or absence of 50 mM urea for 30 min at room
temperature, using the conditions described for EMSA. Total reaction
volume was adjusted to accommodate the desired number of time points.
All samples were loaded onto 5% native acrylamide gel
under current to minimize rUreR·DNA dissociation in the
well. Sample (25 µl) was loaded at the zero time point. Then 100-fold
molar excess of plasmid containing both ureRp and
ureDp (pVJT9, 220 mM) was added to the reaction
mixture, and samples were loaded onto the gel at 15-, 30-, and 60-s
intervals. For calculations, 90 s were added to each time point to
correct for the time required for the sample to migrate into the gel
(24). Gel was analyzed as described for EMSA. Percentage of label
remaining in the complex was determined by densitometry. The fraction
of the DNA remaining in the complex was termed F. In a plot,
where natural log of F was plotted as a function of time,
the slope is equal to k 1, where
k 1 is the dissociation rate constant (25).
Fluorescence Quenching Measurements--
The intrinsic
fluorescence of rUreR, rUreRc, and MBP-UreR was measured
using a PerkinElmer Life Sciences LS 50 luminescence spectrophotometer.
Protein (5-20 mM) was excited at 280 nm, and emission from
310 to 400 nm was recorded. Each sample was scanned 8 to 10 times, and
the emission signal was summed and averaged.
Circular Dichroism Measurements--
Near and far CD spectra of
UreR and mutants were measured with a JASCO J-710/720
spectropolarimeter. Each sample was scanned 40 times at a speed of 50 nm/min, and the signals were summed and averaged. Near UV spectra
(240-320 nm) were determined using a cell path length of 1.0 cm, and
far UV spectra (200-320 nm) were determined using a path length of 0.1 cm. Protein samples used were 0.5 mg/ml for near UV and 0.25 mg/ml for
far UV spectra.
Size Exclusion Chromatography--
The relative molecular
weights of rUreR and rUreRc were predicted by
size-exclusion chromatography using a Sephadex G-75 column with buffers
either with or without 50 mM urea. Size standards were
purchased from Sigma Chemical Co. The presence of protein was
determined by reading absorbance of the fractions at 280 nm.
 |
RESULTS |
UreR Contains a Specific Urea-binding Site--
In the presence of
urea, UreR obtains a transcriptionally active conformation with a high
DNA binding affinity, whereas in the absence of urea, it is not an
efficient activator of transcription and has a lower DNA binding
affinity (21). Because the urea·UreR interaction is critical for
urease gene activation, we asked whether there is a specific
urea-binding site on UreR necessary for a low to high DNA affinity
conformational change. This binding site would differ from the
relatively nonspecific binding responsible for urea denaturation of proteins.
The UreR·urea interaction was assessed by measuring alterations in
the intrinsic fluorescence of the protein as the consequence of ligand
(urea) binding. UreR contains a number of fluorescent aromatic amino
acids, including a single tryptophan residue at position 185 (Trp-185). Recombinant UreR (rUreR, UreR with an N-terminal
6-histidine tag attached, see "Experimental Procedures") was
excited at 280 nm, a wavelength that excites tryptophans, and to a
lesser extent tyrosines, and the emission spectrum from 310 to 400 nm
was recorded (Fig. 1A). This
spectrum peaked at 338.5 nm. In the presence of urea, the relative
fluorescence of the sample decreased as a function of the urea
concentration, while the emission peak remained at 338.5 nm. The
fractional change of the decrease in fluorescence as a function of urea
concentration is shown in Fig. 1B. The shape of the plot
indicates that the observed quenching was due to urea binding UreR at a
single site. Total fluorescence for each peak was summed, and the
change in the mean of this total fluorescence was analyzed using a
curve-fitting algorithm (SigmaPlot). From this algorithm, a
dissociation constant (Kd) of the interaction was
determined to be 0.23 mM (Table
II).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 1.
A, relative fluorescence of rUreR with
increasing concentrations of urea. Protein (20 µM) was
excited at 280 nm, and emission from 310 to 400 nm recorded. Urea
concentrations are as indicated in the inset. B,
fractional change in the decrease of relative fluorescence as a
function of urea concentration.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Affinity of wild-type and mutant rUreR for urea
Affinities were determined by the fluorescence quenching assay
described under "Experimental Procedures."
|
|
In an initial attempt to map the urea-binding site on UreR, an
N-terminal 22-kDa truncate of the proteins was generated. Similar to
other members of the AraC family, UreR contains two C-terminal helix-turn-helix (HTH) motifs that presumably mediate binding to DNA.
rUreR22.0 is the N-terminal 22.0 kDa of the protein that lacks the
second half of the predicted N-terminal HTH, the second C-terminal HTH,
and the remainder of the protein. rUreR22.0 contains Trp-185, the
chromophore likely responsible for the fluorescence change observed.
The affinity of this truncate for urea was essentially identical to
that of wild-type full-length rUreR (Table II). Therefore, the
N-terminal 22 kDa of UreR contains a functional urea-binding site.
Both rUreR and rUreR22.0 contain N-terminal histidine tag sequences.
Because we postulate that histidines might be involved in urea binding
to UreR (see below), it was necessary to determine that the protein,
and not the histidine tag, was responsible for the observed high
affinity urea binding. To do this a maltose binding protein UreR fusion
protein was generated. A decrease in fluorescence was observed when
urea was added to the MBP-UreR fusion, in a similar fashion as observed
with rUreR (not shown). An approximate 0.5 mM
Kd value was predicted, indicating that the urea
binding observed is not due to the recombinant N-terminal histidine tag sequence.
Conformation of rUreR as Predicted by Circular Dichroism--
To
determine the conformational changes associated with urea binding and
subsequent high DNA binding affinity, circular dichroism spectra of
rUreR in the presence and absence of urea were obtained. Both far- and
near-ultraviolet spectra for wild-type rUreR demonstrated little change
when urea was added (Fig. 2). The
far-ultraviolet spectra predicted the secondary structure of the
protein as 56% -helix, 10% sheet, and 33% random coil (Table
III). There was no significant difference
in these percentages when the spectra were obtained in the presence of
urea. Thus, as determined by CD, there was not a detectable
conformational change occurring upon binding urea. This suggests that
the structural differences between activated and urea-free rUreR are
subtle.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 2.
Circular dichroism spectra of wild-type rUreR
in the presence and absence of urea. Each spectrum is the average
of 40 scans. A, far-ultraviolet spectra; B,
near-ultraviolet spectra. Dashed or dotted lines
are for no urea samples, and solid lines are for plus urea
samples.
|
|
Generation of Mutant UreR--
Mutant UreR forms were generated to
identify amino acids comprising the urea-binding site. The urea-binding
site on the enzyme urease is composed of four histidines, one arginine,
and one lysine residue. To test the possibility that UreR contains a
similar urea-binding site, UreR with alanine residues substituted at
positions that normally contain histidine residues were produced.
UreR has seven histidine residues found at positions 73, 102, 107, 175, 186, 205, and 240 (Fig. 3). These
residues are conserved in the primary amino acid sequence of P. mirabilis UreR (27), which is functionally interchangeable with
the P. stuartii UreR (20). By site-directed mutagenesis, the
ureR codons for His-73, His-102, His-107, His-175, and
His-240 were changed to code for alanines. His-186 and His-205 are
found in the predicted N-terminal helix-turn-helix (HTH) motif and thus
were not mutated. Two constructs of each mutant ureR were
generated. To determine the transcriptional activity of each mutant
form, the altered ureR were inserted downstream of the
lactose operon promoter, lacZp, on the low copy number plasmid pRK415. For in vitro studies, each mutated gene was
inserted into the pET15b expression plasmid, and the mutated rUreR were expressed and purified as described.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Amino acid sequence of UreR. The
asterisks highlight positions of histidine residues.
Underlined amino acids are in the predicted helix-turn-helix
motifs.
|
|
There are four possible phenotypes for the mutant proteins: 1) mutant
UreR could appear wild-type and dependent on urea for activity, 2)
mutant protein might have little or no activity, due to loss of a
critical urea binding residue, 3) the protein could be inactive due to
loss of a DNA binding residue or a residue integral to overall
stability and tertiary structure, or 4) the mutant UreR could be active
independent of urea.
In Vivo Activity of Mutant UreR--
The mutated UreR were tested
for their ability to activate transcription at the ureD and
ureR promoters (ureDp and ureRp). Mutant constructs in pRK415 were placed in trans to a single
copy chromosomal ureDp-lacZ and
ureRp-lacZ transcriptional fusions (Fig.
4) (19), and the activity of each mutant
was determined by assaying for -galactosidase (Fig.
5). UreR-His73Ala and UreR-His107Ala exhibited similar activity to that of wild-type UreR. There was no
-galactosidase detected in either the presence or absence of urea
with UreR-His240Ala. UreR-His102Ala and UreR-His175Ala exhibited
activity similar to that of wild-type UreR in the presence of urea, but
were almost as active in the absence of urea. UreR-His102Ala and
UreR-His175Ala were considered to have a constitutive phenotype (UreRc). Therefore, a single substitution at one of two
positions can result in mutant UreR with active urea-independent
conformations. In vivo activity of recombinant UreR was also
measured. This protein has somewhat elevated activity in the absence of
urea but is as active in the presence of urea, when compared with
wild-type UreR. We address this elevated activity under
"Discussion" below.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
The plasmid-encoded urease genes.
A, open boxes represent the urease genes. The
horizontal arrows show the direction of transcription.
ureRp, ureDp, and ureGp are UreR- and
urea-dependent promoters. B, the sequence of the
147-bp fragment containing ureRp and ureDp. The
black line above the sequence indicates the 79-bp
ureRp fragment. The black line below the sequence
indicates the 88-bp ureDp sequence. Highlighted
sequences are the base pairs protected by rUreR in DNase I protection
assays.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
Transcriptional activity of wild-type and
mutant UreR. Plasmids expressing the indicated UreR were placed in
trans to single-copy chromosomal fusions of either
(A) ureDp-lacZ or (B)
ureRp-lacZ. All constructs were under control of
lacZp in pRK415, with the exception of
ureRp-UreR, which is ureR under control of the
ureRp in pRK415. Vector Control is the low copy
plasmid pRK415 with no insert.
|
|
The relative amounts of mutant UreR produced from the pRK415 constructs
were determined by Western analysis. The cultures used above for the
-galactosidase assays were lysed, and the proteins were separated by
SDS-PAGE and immunoblotted with rabbit antibody recognizing rUreR (Fig.
6). Western analysis indicated that
approximately equal amounts of all the mutant proteins were produced,
with the exception of UreR-His240Ala. There was no immunoreactive material seen in the pRK415-UreR-His240Ala lysates, suggesting UreR-His240Ala was not stable. We attributed the lack of
transcriptional activity found in these lysates to the absence of this
protein.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 6.
Expression levels of mutant UreR as
determined by Western analysis. Plasmids are as described in the
Fig. 5 legend.
|
|
rUreRc Have Increased Affinity for DNA in the Absence
of Urea--
Wild-type rUreR has increased affinity for the
DNA-binding site when in the presence of urea. To determine if the
rUreRc exhibited increased DNA affinity in the absence of
urea, electrophoretic mobility shift assays (EMSA) were preformed. The
divergently transcribed plasmid-encoded ureRp and
ureDp map to a 147-bp fragment from the approximate middle
of the 414-bp ureR-ureD intergenic region (Fig.
4). Previously, we demonstrated that there are two independent rUreR-binding sites on this 147-bp segment (20, 21). In EMSA with the
147-bp fragment and rUreR, the mobility of this DNA piece changes (Fig.
7). At low concentrations of rUreR only
one slower migrating band was seen, whereas at the higher
concentrations of rUreR two shifted bands were observed. This change in
migration is sensitive to the presence of urea, and the shifted bands
were seen with lower rUreR concentrations when urea was present.

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 7.
Binding of rUreR and
rUreRc to
ureRp-ureDp. Gel shift assay
using the 147-bp ureRp-Dp fragment. Urea (50 mM) was added to lanes 11-20. C,
control lane with no rUreR added.
|
|
rUreR-His102Ala and rUreR-His175Ala were generated and used in EMSA
(Fig. 7). Both mutant forms were able to bind to the 147 plasmid-encoded ureRp-ureDp containing fragment.
When compared with the interaction of wild-type UreR with the 147-bp
fragment, both rUreR-His102Ala and rUreR-His175Ala showed increased
binding in the absence of urea, indicating the rUreRc had
increased affinity for DNA independent of urea.
Affinity of Wild-type and Mutant rUreR for ureDp--
Previously
we measured the dissociation rate constant
(k 1) of the rUreR·ureDp and
rUreR·ureRp complexes, and found that the half-life of the
complexes increased substantially in the presence of urea (21). Similar
experiments were preformed here to measure the
k 1 of the rUreRc·DNA complexes.
rUreR and mutant rUreR were bound to radiolabeled ureDp as
above for EMSA, 100-fold excess cold DNA was added, and the mix was
loaded quickly onto a 5% acrylamide gel under current (Fig. 8). The loss of radioactivity from the
rUreR- and rUreRc-ureDp band was measured to
determine the dissociation rate constant (Table
IV). As demonstrated previously, in the
absence of urea the rUreR·ureDp complex dissociated with a
rate too rapid to measure, whereas in the presence of urea the
rUreR·ureDp complex had a dissociation half-life of
greater than 250 s. In contrast, in the absence of urea the
rUreR·His102Ala·ureDp complex half-life was ~130 s and
the rUreR·His175Ala·ureDp complex half-life was ~200 s
(Table IV). Therefore, affinity of the mutant rUreR for the DNA-binding
site in the absence of urea was increased and similar to the affinity
of wild-type rUreR for the DNA in the presence of urea. When urea was
added there was no measurable dissociation of the
UreRc·DNA complexes during the course of the experiment,
indicating the half-life of the interaction was greater than 60 min.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 8.
Dissociation of rUreR and rUreRc
from ureDp. rUreR or rUreRc were
bound to the radiolabeled ureDp fragment, in the presence
and absence of urea, and the dissociation was measured after the
addition of 100-fold excess unlabeled fragment. Lanes
indicated consecutive time points as described under "Experimental
Procedures" with (A) lanes 1, 5,
9, and 15 time zero, and (B)
lanes 1, 5, 11, and 15 time
zero.
|
|
Thus, by in vivo transcriptional activity and in
vitro DNA binding measurements, the histidine to
alanine substitutions at position 102 and position 175 result in UreR
forms with a constitutive urea-independent phenotype. These mutant
proteins appear to have the active conformation in the absence of urea.
rUreRc Have Functional Urea Binding Sites--
The
constitutively active rUreR-His102Ala and rUreR-His175Ala were examined
for the ability to bind urea using the fluorescence quenching assay
described above (data not shown). The mutant forms bound urea with an
affinity similar to the affinity of wild-type rUreR for urea (Table
II). The histidine to alanine substitutions that conferred a
constitutive, urea-independent phenotype did not affect urea binding,
and these residues were not likely to be found in the urea-binding site.
Conformation of rUreRc--
Circular dichroism spectra
for the two UreRc were obtained with and without urea.
Similar to the observations with wild-type rUreR, there was little
change in predicted structure when urea was added to the protein
sample. However, the predicted -helical content of the mutants was
decreased, because both rUreRc had ~40% -helical
structure, as compared with 56% for wild-type rUreR (Table III).
Some AraC family members act as dimers (28). As determined by gel
filtration chromatography, rUreR, 34 kDa (Fig.
9) and the two rUreRcs (not
shown) were dimers in both the presence and absence of urea. Each
protein migrated with the bovine serum albumin standard of 66 kDa.
Therefore, activation resulting from either urea binding or loss of the
histidine residues was not associated with the formation of a
dimer.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 9.
Relative molecular weight of rUreR.
rUreR (0.5 mg/ml) was run on a Sephadex G-75 column in buffers
(A) without urea or (B) with 50 mM
urea. Molecular weight standards were also run with and without urea as
appropriate. Dashed line, rUreR; solid line,
standards: 1, bovine serum albumin, 66 kDa; 2,
carbonic anhydrase, 29 kDa; 3, cytochrome C, 12.4 kDa;
4, aprotinin 6.5 kDa.
|
|
 |
DISCUSSION |
The AraC family of transcriptional activators contains
over 100 members and is named after the regulator of the
L-arabinose operon (28). AraC was the first transcriptional
activator identified and was the first member of this family to be
purified and characterized biochemically. Proteins in this family are
characterized by a 17-residue conserved motif and an HTH motif located
in a 100-residue stretch of amino acids (28). A small number of the
proteins in this family also have known signal molecules and signal
receptor domains within the polypeptide. These include AraC, XylS,
MelR, RhaR, and UreR. Although many of the AraC family members are
involved in expression of virulence determinants, of the virulence
associated regulators, only UreR has a known effector molecule and
contains the signal receptor and activator domains on the same molecule.
Transcription of P. stuartii urease genes is dependent on
the presence of the substrate of urease, urea, and UreR. The half-life of the rUreR·DNA association increases when urea is present, and we
believe this increase in affinity is responsible, at least in part, for
the activity of the protein. The relatively modest affinity of rUreR
for urea (Kd of 0.2 mM) correlates with
the levels of urea in environments where urease genes are expressed.
Urea is found at concentrations of up to 10 mM in the blood
and 500 mM in the urine, whereas P. stuartii
requires urea concentrations of 5 mM and greater to
initiate transcription of urease genes. The observed low affinity of
urea for UreR assures that the organism will initiate transcription of
urease genes only in appropriate and biologically relevant environments
that contain a relatively high concentration of urea.
The fluorescence emission profiles of urea-bound and urea-free rUreR
differed, indicating that the environment of an aromatic chromophore
was altered by urea binding. The chromophore is the tryptophane at
position 185.2 Unfortunately,
the involvement of this chromophore does not identify the position of
the urea-binding site, because we cannot conclude with certainty that
this residue is in the urea-binding pocket. To map the urea-binding
site, histidine to alanine substitutions were generated in UreR.
Histidine residues were chosen based on the composition of the
urea-binding site in urease, where histidines coordinate
the binding of a nickel ion, which in turn, interacts with urea. In
urease, specific histidine mutations led to loss of nickel binding and
loss of activity (26). Here, we found the opposite to be true. Only one
histidine residue substitution (UreR-His240Ala) resulted in loss of
activity, and this loss can be attributed to the instability of the
mutant protein. None of the other histidine substitutions led to loss
of urea binding. Thus, the histidine to alanine substitutions did not
specifically localize the urea-binding site. We can state, however,
that the urea-binding site lies on the N-terminal 22.0 kDa of the
protein, because rUreR22.0 bound urea with the same affinity as
wild-type rUreR. This binding site is not on the recombinant N-terminal histidine tag, because the MBP-UreR derivative, which does not contain
a histidine tag, was able to bind urea with an affinity similar to that
of rUreR.
The histidine substitutions did help address another
question. It has been suggested that, similar to the urea-binding site of urease, the UreR urea-binding site may contain nickel. We found no
evidence that this is true. With the exception of rUreR-His240Ala, which is rapidly unstable, loss of the histidines residues did not
result in lost of activity. Therefore, if nickel is present, its
binding is not dependent on histidine residues. Other evidence against
Ni-UreR interaction includes that wild-type UreR did not bind to nickel
affinity columns, nor did it bind to nickel-coated 96-well plates. The
positive control of rUreR, which contains the N-terminal histidine tag,
bound both the column resin and the 96-well nickel-coated plates.
Furthermore, the MBP-UreR fusion protein, which binds urea, was
determined to be metal ion-free by plasma emission analysis using a
Jarrell-Ash ICP plasma emission spectrophotometer. Thus, we conclude
that nickel does not have a physiologic role in the activity of UreR.
Instead of localizing the urea-binding pocket, the histidine
substitutions led to the discovery of two independent
UreRc. These rUreRc have increased affinity for
the DNA-binding site and activate transcription in the absence of urea.
These mutations are not in the urea-binding pocket, because both
mutants bound urea with an affinity equal to the wild-type UreR·urea
interaction. These UreRc indicate that UreR can be
activated either by urea binding or by amino acid residue substitutions
at one of two positions. To understand the conformation changes
resulting in UreR activation, circular dichroism spectra were obtained.
These data predicted that the activation-associated structural changes
are subtle. rUreR and the two rUreRc are dimers in both the
presence and absence of urea. (Recently, P. mirabilis UreR was demonstrated to be a dimer (29).)
Therefore, activation does not result from the formation of a dimer. A
more detailed analysis, such as an x-ray structure, is required to determine differences between the active and inactive conformations.
The in vitro studies performed here used UreR with the
six-histidine tag fused at the N terminus. This protein had elevated activity in the absence of urea when compared with UreR without the
histidine tag. The reason for this elevated activity is unclear and
could result from increased affinity for urea, increased or decreased
kinetics of dimer formation, or changes in DNA binding affinity. The
MBP-UreR shows comparable affinity for urea as rUreR, eliminating urea
binding as a cause. It is demonstrated here that rUreR is a dimer in
the presence and absence of urea, and similar results were reported
with P. mirabilis UreR (29), suggesting the histidine tag
does not affect dimer formation. Thus, this increase in activity
probably results from elevated DNA affinity. We conclude, therefore,
that the DNA binding data presented in Table IV are valid as relative
measurements of the affinities of the recombinant proteins but might
reflect affinities higher than those found in the in vivo
situation. Current experiments are underway to examine the role of the
N terminus of UreR in DNA binding activity.
A key question in the study of microbial pathogens is to identify the
environmental signals triggering the expression of virulence genes. For
the P. stuartii urease genes, that signal is urea. In the
infected urinary tract, urea freely diffuses into the bacteria, where
it binds to UreR. This interaction activates UreR and alerts the
organism of its immediate environment. Thus the UreR·urea complex has
a dual role, acting as both a transcriptional activator as well as an
environmental sensor. Future experiments are needed to determine
whether UreR is a specific regulator of urease genes or if it regulates
the expression, and possible repression, of other plasmid-encoded
and/or chromosomal virulence-associated genes.
 |
ACKNOWLEDGEMENTS |
We are grateful to Keith Brew for assistance
with the fluorescence and CD experiments and for many helpful
discussions. We thank R. Hausinger for helpful discussions.
 |
FOOTNOTES |
*
This work was funded by Public Health Service Grants DK50495
and DK60163 (to C. M. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Current address: Dept. of Internal Medicine, Section of
Rheumatology, P. O. Box 208031, New Haven, CT 06520.
§
To whom correspondence should be addressed (current address): Dept.
of Microbiology, University of Washington School of Medicine, Box
357242, Seattle, WA 98195. Tel.: 206-616-0581; Fax: 206-543-8297; E-mail: carleen@u.washington.edu.
Published, JBC Papers in Press, July 29, 2002, DOI 10.1074/jbc.M203462200
2
M. C. Parra and C. M. Collins, unpublished.
 |
ABBREVIATIONS |
The abbreviations used are:
rUreR, recombinant
UreR;
UreRc, constitutive UreR, UreR that acts in the
absence of urea;
Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol;
MBP, maltose binding protein;
EMSA, electrophoretic mobility shift
assay;
HTH, helix-turn-helix.
 |
REFERENCES |
| 1.
|
Parkinson, J. S.
(1995)
in
Two-component Signal Transduction
(Hoch, J. A.
, and Silhavy, T. J., eds)
, pp. 9-23, American Society for Microbiology, Washington, D. C.
|
| 2.
|
Mekalanos, J. J.
(1992)
J. Bacteriol.
174,
1-7[Free Full Text]
|
| 3.
|
Collins, C. M.,
and D'Orazio, S. E. F.
(1996)
in
Urinary Tract Infections: Molecular Pathogenesis and Clinical Management
(Mobley, H. L. T.
, and Warren, J. W., eds)
, pp. 299-312, American Society of Microbiology, Washington, D. C.
|
| 4.
|
Donnenberg, M. S.,
and Welch, R.
(1996)
in
Urinary Tract Infections: Molecular Pathogenesis and Clinical Management
(Mobley, H. L. T.
, and Warren, J. W., eds)
, pp. 135-174, American Society of Microbiology, Washington, D. C.
|
| 5.
|
Mobley, H. L. T.
(1996)
in
Urinary Tract Infections: Molecular Pathogenesis and Clinical Management
(Mobley, H. L. T.
, and Warren, J. W., eds)
, pp. 245-269, American Society of Microbiology, Washington, D. C.
|
| 6.
|
Collins, C. M.,
Gutman, D. M.,
and Laman, H.
(1993)
Mol. Microbiol.
8,
187-198[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Braude, A. I.,
and Siemienski, J.
(1960)
J. Bacteriol.
80,
171-179[Free Full Text]
|
| 8.
|
Griffith, D. P.,
Musher, D. M.,
and Itin, C.
(1976)
Invest. Urol.
13,
346-350[Medline]
[Order article via Infotrieve]
|
| 9.
|
Mobley, H. L. T.,
and Warren, J. W. J.
(1987)
Clin. Microbiol.
25,
2216-2217
|
| 10.
|
Lerner, S. P.,
Gleeson, M. J.,
and Griffith, D. P.
(1989)
J. Urol.
141,
753-758[Medline]
[Order article via Infotrieve]
|
| 11.
|
Fowler, J. E. J.
(1984)
J. Urol.
131,
213-215[Medline]
[Order article via Infotrieve]
|
| 12.
|
MacLaren, D. M.,
and Peerbooms, P. G. H.
(1986)
in
Microbial Diseases in Nephrology
(Brumfit, A. W., ed)
, pp. 183-195, John Wiley & Sons, New York
|
| 13.
|
Warren, J. W.
(1996)
in
Urinary Tract Infections: Molecular Pathogenesis and Clinical Management
(Mobley, H. L. T.
, and Warren, J. W., eds)
, pp. 3-27, American Society of Microbiology, Washington, D. C.
|
| 14.
|
Mobley, H. L.,
Chippendale, G. R.,
Fraiman, M. H.,
Tenney, J. H.,
and Warren, J. W.
(1985)
J. Clin. Microbiol.
22,
851-853[Abstract/Free Full Text]
|
| 15.
|
Collins, C. M.,
and Falkow, S.
(1990)
J. Bacteriol.
172,
7138-7144[Abstract/Free Full Text]
|
| 16.
|
D'Orazio, S. E. F.,
and Collins, C. M.
(1993)
J. Bacteriol.
175,
1860-1864[Abstract/Free Full Text]
|
| 17.
|
Lee, M. H.,
Mulrooney, S. B.,
Renner, M. J.,
Markowicz, Y.,
and Hausinger, R. P.
(1992)
J. Bacteriol.
174,
4324-4330[Abstract/Free Full Text]
|
| 18.
|
D'Orazio, S. E. F.,
and Collins, C. M.
(1993)
J. Bacteriol.
175,
3459-3467[Abstract/Free Full Text]
|
| 19.
|
D'Orazio, S. E. F.,
and Collins, C. M.
(1995)
Mol. Microbiol.
16,
145-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
D'Orazio, S. E. F.,
Thomas, V.,
and Collins, C. M.
(1996)
Mol. Microbiol.
21,
643-655[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Thomas, V. J.,
and Collins, C. M.
(1999)
Mol. Microbiol.
31,
1417-1428[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Ho, S. N.,
Hunt, H. D.,
Horton, R. M.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene
77,
51-59[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Miller, J. H.
(1972)
Experiments in Molecular Genetics
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 24.
|
Hendrickson, W.,
and Schleif, R. F.
(1984)
J. Mol. Biol.
178,
611-628[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Revzin, A.
(1989)
BioTechniques
7,
346-355[Medline]
[Order article via Infotrieve]
|
| 26.
|
Jabri, E.,
Carr, M. B.,
Hausinger, R. P.,
and Karplus, P. A.
(1995)
Science
268,
998-1004[Abstract/Free Full Text]
|
| 27.
|
Nicholson, E. B.,
Concaugh, E. A.,
Foxall, P. A.,
Island, M. D.,
and Mobley, H. L.
(1993)
J. Bacteriol.
175,
465-473[Abstract/Free Full Text]
|
| 28.
|
Gallegos, M. T.,
Schleif, R.,
Bairoch, A.,
Hofmann, K.,
and Ramos, J. L.
(1997)
Microbiol. Mol. Biol. Rev.
61,
393-410[Abstract]
|
| 29.
|
Poore, C. A.,
Coker, C.,
Dattelbaum, J. D.,
and Mobley, H. L.
(2001)
J. Bacteriol.
183,
4526-4535[Abstract/Free Full Text]
|
| 30.
|
Keen, N. T.,
Tamaki, S.,
Kobayashi, D.,
and Trollinger, D.
(1988)
Gene
70,
191-197[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. N. Basturea, M. D. Bodero, M. E. Moreno, and G. P. Munson
Residues near the Amino Terminus of Rns Are Essential for Positive Autoregulation and DNA Binding
J. Bacteriol.,
April 1, 2008;
190(7):
2279 - 2285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Poore and H. L. T. Mobley
Differential regulation of the Proteus mirabilis urease gene cluster by UreR and H-NS
Microbiology,
December 1, 2003;
149(12):
3383 - 3394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Recchi, B. Sclavi, J. Rauzier, B. Gicquel, and J.-M. Reyrat
Mycobacterium tuberculosis Rv1395 Is a Class III Transcriptional Regulator of the AraC Family Involved in Cytochrome P450 Regulation
J. Biol. Chem.,
September 5, 2003;
278(36):
33763 - 33773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Dattelbaum, C. V. Lockatell, D. E. Johnson, and H. L. T. Mobley
UreR, the Transcriptional Activator of the Proteus mirabilis Urease Gene Cluster, Is Required for Urease Activity and Virulence in Experimental Urinary Tract Infections
Infect. Immun.,
February 1, 2003;
71(2):
1026 - 1030.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|